futoxide has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, BB; Chaturvedi, MM; Hema, PS; Nair, MS; Prasad, S; Reuter, S; Sundaram, C; Yadav, VR | 1 |
| Eldridge, GR; Goering, MG; Hu, JF; Lawrence, JA; Norman, VL; O'Neil-Johnson, M; Rice, SM; Starks, CM; Williams, RB | 1 |
2 other study(ies) available for futoxide and Benign Neoplasms
| Article | Year |
|---|---|
Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway.
Topics: Angiogenesis Inducing Agents; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Epoxy Compounds; Humans; Inflammation Mediators; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Zingiberaceae | 2010 |
Polyoxygenated cyclohexene derivatives from Monanthotaxis congoensis.
Topics: Annonaceae; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cyclohexenes; Epoxy Compounds; Humans; Molecular Structure; Neoplasms; Plant Extracts | 2012 |